Analysts’ downgrades for Sunday, September 13th: Beam Therapeutics (NASDAQ:BEAM) was downgraded by analysts at Wall Street Zen from a sell rating to a strong sell rating. Cullinan Therapeutics (NASDAQ:CGEM) was downgraded by analysts at Wall Street Zen from a hold rating to a sell rating. Cognex (NASDAQ:CGNX) was downgraded by analysts at Wall Street Zen […]